Treatment of transurethral resection of the prostate.
Phase 2
- Conditions
- Prostatic hyperplasia.Hyperplasia of prostate
- Registration Number
- IRCT20110306005981N3
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Age range of 50-80 years
Lower urinary tract symptoms resistant to standard medical treatment
international prostate symptom score (IPSS) of >12
prostate volume of >50 cm3 in ultrasound
Exclusion Criteria
History of prostate surgery
Having prostate cancer
Having bleeding disorders
Incidence of acute urinary retention during the treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms (e.g., dysuria, urinary frequency, and pelvic pain). Timepoint: 3, 6, and 12 months after the intervention. Method of measurement: The international prognostic scoring system (IPSS).
- Secondary Outcome Measures
Name Time Method